---
$id: https://graph.org.ai/products/commodity/51141564
$type: Product
source: UNSPSC
code: "51141564"
title: "Nonapyrimine"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nonapyrimine

**UNSPSC Code**: 51141564
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C15H24N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 322D5Y3Q0G, chemically known as 7h-pyrrolo(2,3-d)pyrimidine, 4-(nonylamino)- but generally known as nonapyrimine, which bears US NIH Compound Identifier 3047795. European Medicines Agency schedules Nonapyrimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09350MIG. The term NONAPYRIMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). NONAPYRIMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nonapyrimine under HS 29335995 and SITC 51576. As of Q4 2014, NONAPYRIMINE remains the US FDA Preferred Term for this commodity. Nonapyrimine bears US NLM identifiers UMLS ID C2698489 and NCI Concept Code C75164. SMILES: N(CCCCCCCCC)C1NCNC2[NH]CCC12.

